Inventor · disambiguated record
Xiao He
Also filed as: HE XIAO · HE XIAO-SHU
56 granted patents·10 pending applications·598 citations·filing 1991–2020
98Inventor score
Top patents by PatentIndex Score
66 records- 0196US7705018B2Substituted quinolines and their uses in treatment of inflammatory and related conditionsAMGEN INC·Filed 2008·Granted Apr 27, 2010·51 cites·10 claims
- 0295US5679673AAralkyl bridged diazabicycloalkane derivatives for CNS disordersUS HEALTH·Filed 1994·Granted Oct 21, 1997·74 cites·21 claims
- 0394US6432958B12-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 2001·Granted Aug 13, 2002·33 cites·19 claims
- 0491US8586739B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Nov 19, 2013·13 cites·7 claims
- 0591US8193199B2Heterocyclic compounds and their usesCHEN YI·Filed 2008·Granted Jun 5, 2012·15 cites·15 claims
- 0691US6723743B1High affinity small molecule C5a receptor modulatorsNEUROGEN CORP·Filed 2000·Granted Apr 20, 2004·32 cites·44 claims
- 0791US5171750ASubstituted phenserines as specific inhibitors of acetylcholinesteraseUS HEALTH·Filed 1991·Granted Dec 15, 1992·56 cites·14 claims
- 0890US8575183B2Heterocyclic compounds and their usesCUSHING TIMOTHY DAVID·Filed 2011·Granted Nov 5, 2013·26 cites·5 claims
- 0990US7919498B2Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitorsAMGEN INC·Filed 2008·Granted Apr 5, 2011·16 cites·7 claims
- 1089US6284759B12-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1999·Granted Sep 4, 2001·40 cites·19 claims
- 1183US6482844B11-benzylimidazole derivativesNEUROGEN CORP·Filed 2001·Granted Nov 19, 2002·13 cites·22 claims
- 1283US6245768B11-(N′-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1999·Granted Jun 12, 2001·31 cites·8 claims
- 1381US6846834B2Antiinflammation agentsAMGEN INC·Filed 2001·Granted Jan 25, 2005·15 cites·73 claims
- 1480US8901135B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Dec 2, 2014·3 cites·16 claims
- 1580US6884815B1High affinity small molecule C5a receptor modulatorsNEUROGEN CORP·Filed 2003·Granted Apr 26, 2005·9 cites·48 claims
- 1679US8329910B2Quinolines for the treatment of PI3K-δ mediated diseasesCHEN YI·Filed 2011·Granted Dec 11, 2012·3 cites·10 claims
- 1779US7605289B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2006·Granted Oct 20, 2009·4 cites·42 claims
- 1879US7186841B2Antiinflammation agentsSYNTEX LLC·Filed 2004·Granted Mar 6, 2007·11 cites·4 claims
- 1978US8765940B2Heterocyclic compounds and their usesBROWN MATTHEW·Filed 2010·Granted Jul 1, 2014·5 cites·5 claims
- 2078US7402704B2Arylsulfones and uses related theretoAMGEN INC·Filed 2005·Granted Jul 22, 2008·3 cites·18 claims
- 2175US6509366B2Substituted imidazoles as selective modulators of Bradykinin B2 receptorsNEUROGEN CORP·Filed 2001·Granted Jan 21, 2003·7 cites·46 claims
- 2273US9873701B2Heterocyclic compounds and their usesAMGEN INC·Filed 2014·Granted Jan 23, 2018·1 cites·16 claims
- 2373US5571832ANitrogen-containing cyclohetero alkylamino aryl derivatives for CNS disordersUS ARMY·Filed 1994·Granted Nov 5, 1996·14 cites·12 claims
- 2471US5569447AStannylated 3-quinuclidinyl benzilates and methods of preparing radiohalogenated derivativesUS HEALTH·Filed 1994·Granted Oct 29, 1996·17 cites·35 claims
- 2571US5378723ACarbamate analogs of thiaphysovenine and method for inhibiting cholinesterasesUS HEALTH·Filed 1994·Granted Jan 3, 1995·24 cites·14 claims
- 2670US8119665B2Aryl imidazoles and related compounds as C5a receptor modulatorsLUKE GEORGE P·Filed 2007·Granted Feb 21, 2012·2 cites·13 claims
- 2767US6288230B12-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1999·Granted Sep 11, 2001·11 cites·35 claims
- 2867US2020048265A1Heterocyclic compounds and their usesAMGEN INC·Filed 2019·Application pending·0 cites
- 2963US5602168A1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted Feb 11, 1997·9 cites·7 claims
- 3063US2018105532A1Heterocyclic compounds and their usesAMGEN INC·Filed 2017·Application pending·0 cites
- 3162US6100255A3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1998·Granted Aug 8, 2000·7 cites·29 claims
- 3261US7365075B2Aryl sulfonamide compounds and uses related theretoAMGEN INC·Filed 2004·Granted Apr 29, 2008·1 cites·46 claims
- 3361US7271270B2High affinity small molecule C5a receptor modulatorsNEUROGEN CORP·Filed 2004·Granted Sep 18, 2007·1 cites·18 claims
- 3460US5679679AAralkyl diazabicycloalkane derivatives for CNS disordersUS HEALTH·Filed 1994·Granted Oct 21, 1997·6 cites·20 claims
- 3559US8637576B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2009·Granted Jan 28, 2014·0 cites·4 claims
- 3659US6031097A1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1998·Granted Feb 29, 2000·5 cites·26 claims
- 3759US5744472A1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted Apr 28, 1998·7 cites·6 claims
- 3859US5656632A1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted Aug 12, 1997·6 cites·14 claims
- 3958US8183259B2Heterocyclic compounds and their usesCHEN YI·Filed 2011·Granted May 22, 2012·0 cites·8 claims
- 4058US7754890B2Arylsulfones and uses related theretoAMGEN INC·Filed 2008·Granted Jul 13, 2010·0 cites·11 claims
- 4157US8183258B2Heterocyclic compounds and their usesCHEN YI·Filed 2011·Granted May 22, 2012·0 cites·10 claims
- 4257US2007135464A1Antiinflammation agentsAMGEN INC·Filed 2007·Application pending·0 cites
- 4356US7241765B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2006·Granted Jul 10, 2007·0 cites·44 claims
- 4454US5346908ANitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disordersUS HEALTH·Filed 1992·Granted Sep 13, 1994·3 cites·12 claims
- 4552US5972945A2-aminoalkylaminoquinolines; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1998·Granted Oct 26, 1999·4 cites·22 claims
- 4652US2010179177A1Heterocyclic compounds and their usesAMGEN INC·Filed 2010·Application pending·0 cites
- 4751US5932729A1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1997·Granted Aug 3, 1999·3 cites·1 claims
- 4851US2011086834A1Alkynyl alcohols as kinase inhibitorsAMGEN INC·Filed 2009·Application pending·0 cites
- 4950US5656625ANitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disordersUS HEALTH·Filed 1995·Granted Aug 12, 1997·3 cites·29 claims
- 5050US2022363758A1Heterodimeric Antibodies That Bind to CD38 and CD3SORRENTO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiao He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →